immune system
|
• following adoptive transfer, naive CD8+ T cells exhibit no proliferation in RIP-ovalow recipients unlike similarly treated wild-type cells
|
|
• following adoptive transfer, T cells exhibit increased cell intrinsic proliferation in RIP-ovahigh recipients unlike similarly treated wild-type cells
|
|
• following adoptive transfer, CD8+ T cells induce peri-ductal infiltrates and vasculitis within the pancreas in RIP-ovahigh recipients unlike similarly treated wild-type cells
|
|
• following adoptive transfer, CD8+ T cells induce severe insulitis in RIP-ovahigh recipients unlike similarly treated wild-type cells
|
|
• following adoptive transfer, CD8+ T cells fail to undergo cross-tolerization when transplanted into RIP-ovahigh recipients unlike similarly treated wild-type cells
|
|
• following adoptive transfer, CD8+ T cells induce diabetes in RIP-ovahigh or RIP-ovalow recipients unlike similarly treated wild-type cells
|
cardiovascular system
|
• following adoptive transfer, CD8+ T cells induce vasculitis within the pancreas in RIP-ovahigh recipients unlike similarly treated wild-type cells
|
endocrine/exocrine glands
|
• following adoptive transfer, CD8+ T cells induce peri-ductal infiltrates and vasculitis within the pancreas in RIP-ovahigh recipients unlike similarly treated wild-type cells
|
|
• following adoptive transfer, CD8+ T cells induce severe insulitis in RIP-ovahigh recipients unlike similarly treated wild-type cells
|
hematopoietic system
|
• following adoptive transfer, naive CD8+ T cells exhibit no proliferation in RIP-ovalow recipients unlike similarly treated wild-type cells
|
|
• following adoptive transfer, T cells exhibit increased cell intrinsic proliferation in RIP-ovahigh recipients unlike similarly treated wild-type cells
|
cellular
|
• following adoptive transfer, naive CD8+ T cells exhibit no proliferation in RIP-ovalow recipients unlike similarly treated wild-type cells
|
|
• following adoptive transfer, T cells exhibit increased cell intrinsic proliferation in RIP-ovahigh recipients unlike similarly treated wild-type cells
|


Analysis Tools